Insight Molecular Diagnostics Inc. Capital Reinvestment Ratio

Latest as of September 2014: 1.86x

Insight Molecular Diagnostics Inc. capital reinvestment ratio. Insight Molecular Diagnostics Inc. (IMDX) has a Capital Reinvestment Ratio of 1.86x as of September 2014, meaning it reinvests 2% of its operating cash flow ($7.00K) in capital expenditures ($13.00K). See how much free cash does Insight Molecular Diagnostics Inc. generate to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.86x

Capex / Operating Cash Flow

Operating Cash Flow

$7.00K

USD

Capital Expenditures

$13.00K

USD

Data as of

Sep 2014

Most recent filing

Insight Molecular Diagnostics Inc. Capital Reinvestment Ratio by Year (None–None)

Insight Molecular Diagnostics Inc. capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Insight Molecular Diagnostics Inc. (IMDX) cash flow conversion.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow